InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
59%
T+90 mean return
+3.6%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Pizzuti Dana, Chief Med and Dev Officer. Director active across 1 company, notably Crinetics Pharmaceuticals, Inc.. In total, 20 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €75k. History available since 10 October 2022. The latest transaction was disclosed on 1 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations20 total
5,000 shares@ US$16.8925.1% of flowCommon StockSEC:0001628280-25-055054
5,000 shares@ US$16.890.0016% mcap25.1% of flowCommon StockSEC:0001628280-25-055054:0
5,000 shares@ US$16.890.0016% mcap24.9% of flowCommon StockSEC:0001658247-25-000013:0
5,000 shares@ US$16.8924.9% of flowCommon StockSEC:0001658247-25-000013
2,388 shares@ US$34.173.7% of flowCommon StockSEC:0000950170-25-043407:0
43,000 shares0Common StockSEC:0000950170-25-025665:0
5,000 shares@ US$16.894.1% of flowCommon StockSEC:0000950170-25-014557:0
15,000 shares@ US$16.8912.1% of flowCommon StockSEC:0000950170-25-002869:0
14,375 shares@ US$16.8910.8% of flowCommon StockSEC:0000950170-24-113082:0
14,375 shares@ US$16.8911.1% of flowCommon StockSEC:0000950170-24-081878:0
9,500 shares@ US$16.897.4% of flowCommon StockSEC:0000950170-24-077402:0
14,375 shares@ US$16.8911.2% of flowCommon StockSEC:0000950170-24-045142:0
4,375 shares@ US$16.893.3% of flowCommon StockSEC:0001209191-24-005061:0
411 shares@ US$38.140.7% of flowCommon StockSEC:0001209191-24-005013:0
23,000 shares0Common StockSEC:0001209191-24-004607:0
14,375 shares@ US$16.8910.9% of flowCommon StockSEC:0001209191-24-000816:0
9,583 shares@ US$16.897.3% of flowCommon StockSEC:0001209191-23-059628:0
4,288 shares@ US$15.983.1% of flowCommon StockSEC:0001209191-23-023469:0
4,500 shares0Common StockSEC:0001209191-23-015609:0
12,500 shares0Common StockSEC:0001209191-22-053313:0
20 of 20 declarations
About Pizzuti Dana
Dana Pizzuti serves as Chief Medical and Development Officer at Crinetics Pharmaceuticals, Inc. She is responsible for overseeing the company's medical and development initiatives, contributing to the creation of innovative treatments for patients. Her expertise is crucial for the success of clinical projects.
